NEW YORK (GenomeWeb) – Molecular diagnostics firm Curetis has established a wholly owned subsidiary Ares Genetics that will focus on developing antibiotic resistance tests, the company said this week.

Ares Genetics, headquartered in Vienna, Austria, will harness the Genetic Antibiotic Resistance and Susceptibility Database (GEAR) that Curetis recently acquired from Siemens to understand the genetic basis for antibiotic resistance.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.